Worldwide Lead Optimisation Outsourcing Market to Amount to USD 8.12 Billion by 2023, According to Visiongain

16 Jan 2013 • by Natalie Aster

By 2023, the global lead optimisation outsourcing market will reach $8.12bn, growing at a CAGR of 8.8% between 2018 and 2023. This discovery outsourcing segment will increase it market share from 21.5% in 2017 to 22.8% in 2023. Visiongain believes that growth in this market will be driven by the progressive decline in the blockbuster pharma model as many pharmaceutical companies consolidate their resources and try to reduce their operating budgets. According to the new report “Drug Discovery Outsourcing: World Market 2013-2023” by Visiongain, outsourcing activities will increase. More specifically, as R&D budgets are cut, pharma companies will be keen to improve the efficiency of their discovery and development processes. Installing early ADMET testing will help avoid failure and costs at later development stages. Other areas in lead optimisation, such as analogues creation and computational support will also provide cost cutting incentives, promoting market growth.

Report Details:

Drug Discovery Outsourcing: World Market 2013-2023
Published: November, 2012
Pages: 157
Price: US$ 2,497.00

More information can be found in the report “Drug Discovery Outsourcing: World Market 2013-2023” by Visiongain.

To order the report or ask for sample pages contact


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970